· Boehringer Ingelheim has been recognized as one of the 16 Top Employers Worldwide by the Top Employers Institute for its long-term strategic orientation, modern management culture and strong employee communication practices
· ‘Top Employer’ recognition awarded to Boehringer Ingelheim Saudi Arabia for its strong employee culture, development and support programs
· In total, 27 Boehringer Ingelheim offices were recognized as ‘Top Employers’ in their respective country categories across Europe, Latin America and Asia-Pacific
Dubai, United Arab Emirates: Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, has been recognized for the very first time as a ‘Global Top Employer for 2021’ by the prestigious Top Employers Institute.
This year as a ‘Global Top Employer’, Boehringer Ingelheim joins the ranks of 16 other international organizations to receive this outstanding honor. While the organization has received awards on a country level for the past seven years, and in addition to the global award, the company has been further recognized as a ‘Top Employer’ across 27 country categories, spanning the European, Asia-Pacific, Latin-American and Middle Eastern regions.
The independent Top Employers Institute certifies employers worldwide who wish to offer their employees excellent working conditions and support their development. Certification is based on a multi-level program to examine human resources management with detailed final feedback. Boehringer Ingelheim particularly impressed the certification board with its long-term strategic orientation, its modern management culture as well as strong employee communication practices, with its inclusive corporate culture also cited as a highlight. The jury found the organization’s ethical, inclusive approach to corporate decisions and a clear focus on the transfer and application of company values, to be highly commendable.
“Receiving such a prestigious award for our efforts, despite the challenges faced in the past year, reflects the company focus on its employees as its main asset,” said Mohammed Al-Tawil, Country Managing Director and Head of Human Pharma META at Boehringer Ingelheim. “Strengthening our employee experience & capabilities is absolutely critical to our overarching strategy, as we rely on our teams to materialize our mission of creating value through innovation.”
A regional highlight coveted by Boehringer Ingelheim in the Middle East Region, was the ‘Top Employer’ recognition for its Saudi operation. “We are also delighted to have our Saudi offices recognized as a ‘Top Employer’ within their country division, stemming from the strong leadership, development and growth demonstrated by the team,” Tawil continued.
On her part, Birgit Giokalas, Human Resources Director for the region META shares, “We pride ourselves for our employee-centric approach to operations, as we make sure to offer our teams the support, infrastructure and corporate engagement required to succeed in the industry. An example of employee orientation that comes to mind are the areas around agile working methodologies. In this area, that has been in our focus for quite some time before COVID, among other, to ensure that during the pandemic, employees were able to quickly adapt their working styles to align with health protection requirements and to ensure business continuity. We have also worked on the future of work for the time after the pandemic to ensure the learnings and working style will continue and evolve in the years to come.
For 135 years, Boehringer Ingelheim has been creating value through innovation for human and animal health, dedicating itself to a better world. It aims to meet this through excellent HR policies and people practices, covering domains such as people strategy, work environment, talent acquisition, learning, well-being, diversity, inclusion and more. The family business invests heavily in individual development opportunities through tailor-made education and training programs for all employees. This serves to enhance its existing progressive workplace culture promoting transparency, open communication and supportive forward-looking campaigns.
Boehringer Ingelheim will continue on its journey to implement further employee-focused initiatives, ensuring the growth, development and overarching wellbeing of its teams.
About Boehringer Ingelheim:
Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good.
As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of 19 billion euros. Our significant investment of almost 3.5 billion euros in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.
We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.